FDA
-
-
-
-
-
-
-
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
-
-
-
-
-
-
-
Revelation Biosciences implements 1-for-4 reverse stock split
-
-
-
-
-
-
-
Revelation Biosciences begins GMP manufacturing of GEMINI drug and placebo
-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
-
-
-
-
-
-
-
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
-
-
-
-
-
-
-
Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors
-
-
-
-
-
-
-
Revelation Biosciences (REVB) Announces 1:16 Reverse Share Split
-
330,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

